Evaluation of antimicrobial and antiplatelet aggregation effects of Solidago chilensis Meyen
DOI:
https://doi.org/10.22377/ijgp.v3i1.53Abstract
Solidago species have been used in popular medicine for the treatment of several inflammatory conditions. The aim of this study is to evaluate both the antimicrobial and antiplatelet effects of Solidago chilensis Meyen rhizome aqueous extract and its derived fractions using in-vitro models. The antimicrobial analysis was performed against Staphylococcus aureus (ATCC 25922), Escherichia coli (ATCC 25923) and Pseudomonas aeruginosa (ATCC 27853). The broth microdilution method was used to determine the minimal inhibitory concentration (MIC). The measurement of platelet aggregation was determined by turbidimetric methodology. Significant differenceswere determined by analysis of variance (ANOVA), Dunnett’s or Student’s t tests. Values of P < 0.05 were considered significant. Theaqueous extract and its derived fractions prevented the growth of all the three tested microbial species. Furthermore, these extracts also significantly inhibited platelet aggregation (% of inhibition: AE: 45.0±4.0%, BuOH: 29.6±3.1% to 13.8±2.6%, and AR: 41.7±4.2%). Solidago chilensis Meyen rhizomes demonstrated important antimicrobial and antiplatelet aggregation activities, which may underlie their beneficial effect on bacterial infection and atherothrombotic diseases.
Key words: Antimicrobial effect, antiplatelet activity, Solidago chilensis Meyen
Downloads
References
Melzig MF. Goldenrod: A classical exponent in the urological
phytotherapy. Wien Med Wochenschr 2004;154:523-7.
Morel AF, Dias GO, Porto C, Simionatto E, Stuker CZ,
Dalcol II. Antimicrobial activity of extractives of Solidago
microglossa. Fitoterapia 2006;77:453-5.
Sampson JH, Phillipson JD, Bowery NG, O’neill MJ, Houston JG,
Lewis JA. Ethnomedicinally selected plants as sources of potential
analgesic compounds: Indication of in-vitro biological activity in
receptor binding assays. Phytother Res 2000;14:24-9.
Gross SC, Goodarzi G, Watabe M, Bandyopadhyay S, Pai SK,
Watabe K. Antineoplasic activity of Solidago virgaurea on prostatic
tumor cells in an SCID mouse model. Nutr Cancer 2002;43:76-81.
McCune LM, Johns T. Antioxidant activity in medicinal plants
associated with the symptoms of diabetes mellitus used by
the indigenous peoples of the North American boreal forest.
J Ethnopharmacol 2002;82:197-205.
Lorenzi H, Matos FJ. Plantas Medicinais no Brasil - Nativas e
exóticas, Instituto Plantarum de Estudos da Flora. São Paulo,
Brazil: 2002.
Brazilian Pharmacopoeia, Companhia Editora Nacional. São
Paulo, Brazil: 1929.
Batyuk VS, Kovaleva SN. Flavonoids of Solidago canadensis and
Solidago virgaurea. Khimiia Prirodnykh Soedinenii 1985;21:566-7.
Kim DW, Chi YS, Son KH, Chang HW, Kim JS, Kang SS, et al.
Effects of sophoraflavanone G, a prenylated flavonoid from
Sophora flavescens, on cyclooxygenase-2 and in-vivo inflammatory
response. Arch Pharm Res 2002;25:329-35.
Mbaveng AT, Ngameni B, Kuete V, Simo IK, Ambassa P, Roy R,
et al. Antimicrobial activity of the crude extracts and five flavonoids
from the twigs of Dorstenia barteri (Moraceae). J Ethnopharmacol
;116:483-9.
Koleckar V, Brojerova E, Rehakova Z, Kubikova K, Cervenka F,
Kuca K, et al. In-vitro antiplatelet activity of flavonoids from Leuzea
carthamoides. Drug Chem Toxicol 2008;31:27-35.
Wu B, Takahashi T, Kashiwagi T, Tebayashi S, Kim CS. New
flavonoid glycosides from the leaves of Solidago altissima. Chem
Pharm Bull (Tokyo) 2007;55:815-6.
Apáti P, Houghton PJ, Kéry A. HPLC investigation of antioxidant
components in Solidago herba. Acta Pharm Hung 2004;74:223-31.
Gutierrez AB, Oberti JC, Juliani HR. Constituents of Solidago
chilensis (Compositae). Anales. Asociación de Quimica del
Argentina 1981;69:27-31.
Steliopoulos P, Wüst M, Adam KP, Mosandl A. Biosynthesis of the
sesquiterpene germacrene D in Solidago canadensis: 13C and (2) H
labeling studies. Phytochemistry 2002;60:13-20.
Bradette-Hébert ME, Legault J, Lavoie S, Pichette A. A new labdane
diterpene from the flowers of Solidago canadensis. Chem Pharm
Bull 2008;56:82-4.
Apáti P, Houghton PJ, Kite G, Steventon GB, Kéry A. In-vitro effect
of flavonoids from Solidago canadensis extract on glutathione
S-transferase. J Pharm Pharmacol 2006;58:251-6.
Bader G, Wray V, Hiller K. The main saponins from the aerial
parts and the roots of Solidago virgaurea subsp. virgaurea. Planta
Med 1995;61:158-61.
Zeng FR, Yin SM, Xie SF, Nie DN, Ma LP, Feng JH, et al. Effects of
A-1-1 on the aggregation and Ca2+ influx of platelets. Zhonghua
Xue Ye Xue Za Zhi 2004;25:544-7.
Almeida AA, Farah A, Silva DA, Nunan EA, Glória MB.
Antibacterial activity of coffee extracts and selected coffee
chemical compounds against enterobacteria. J Agric Food Chem
;54:8738-43.
Avato P, Bucci R, Tava A, Vitali C, Rosato A, Bialy Z, et al.
Antimicrobial activity of saponins from Medicago sp.: Structureactivity
relationship. Phytother Res 2006;20:454-7.
Thisoda P, Rangkadilok N, Pholphana N, Worasuttayangkurn L,
Ruchirawat S, Satayavivad J. Inhibitory effect of Andrographis
paniculata extract and its active diterpenoids on platelet
aggregation. Eur J Pharmacol 2006;553:39-45.
Hsu HC, Yang WC, Tsai WJ, Chen CC, Huang HY, Tsai YC.
Alpha-bulnesene: A novel PAF receptor antagonist isolated
from Pogostemon cablin. Biochem Biophys Res Commun
;345:1033-8.
Kuzma Å, Rózalski M, Walencka E, Rózalska B, WysokiÅ„ska H.
Antimicrobial activity of diterpenoids from hairy roots of
Salvia sclarea L.: Salvipisone as a potential anti-biofilm agent
active against antibiotic resistant Staphylococci. Phytomedicine
;14:31-5.
Lee JJ, Jin YR, Lee JH, Yu JY, Han XH, Oh KW, et al. Antiplatelet
activity of carnosic acid: A phenolic diterpene from Rosmarinus
officinalis. Planta Med 2007;73:121-7.
Satake T, Kamiya K, An Y, Oishi Nee Taka T, Yamamoto J. The
anti-thrombotic active constituents from Centella asiatica. Biol
Pharm Bull 2007;30:935-40.
Djeddi S, Karioti A, Sokovic M, Koukoulitsa C, Skaltsa H. A novel
sesquiterpene lactone from Centaurea pullata: Structure elucidation,
antimicrobial activity, and prediction of pharmacokinetic
properties. Bioorg Med Chem 2008;16:3725-31.
Natella F, Nardini M, Belelli F, Pignatelli P, Di Santo S, Ghiselli A,
et al. Effect of coffee drinking on platelets: inhibition of aggregation
and phenols incorporation. Br J Nutr 2008;28:1-7.
Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RA.
Manual of Clinical Microbiology. 8th ed. Washington, DC: ASM
Press; 2003.
National Committee for Clinical Laboratory Standards (CLSI),
Performance standards for antimicrobial susceptibility testing,
Fifteenth Informational Supplement M100-S15, Wayne, PA:
Drummond AJ, Waigh RD. Recent Research Developments in
Phytochemistry 2000;4:143-52.
Born GV, Cross MJ. Aggregation of blood platelets. J Physiol
;168:178-95.
Rossi A, Longo R, Russo A, Borrelli F, Sautebin L. The role of the
phenethyl ester of caffeic acid (CAPE) in the inhibition of rat lung
cyclooxygenase activity by propolis. Fitoterapia 2002;73:30-7.
Campos FM, Couto JA, Hogg TA. Influence of phenolic acids on
growth and inactivation of Oenococcus oeni and Lactobacillus
hilgardii. J Appl Microbiol 2003;94:167-74.
Park JB. Caffedymine from cocoa has COX inhibitory activity
suppressing the expression of a platelet activation marker,
P-selectin. J Agric Food Chem 2007;55:2171-5.
